ScottsMiracle-Gro Announces Record Full Year Results as Fourth Quarter Sales Exceed Expectations in U.S. Consumer Segment
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Scotts Miracle-Gro (SMG) PT Raised to $180 at Stifel
November 4, 2021 7:29 AM EDTStifel analyst W. Andrew Carter raised the price target on Scotts Miracle-Gro (NYSE: SMG) to $180.00 (from $175.00) while maintaining a Buy rating.
The analyst commented, "Initial FY22 EPS guidance ($8.50 - $8.90) well above expectations (consensus $8.44, Stifel $8.31) as the company contends with input cost inflation, slower... More
Scotts Miracle-Gro (SMG) Tops Q4 EPS by 2c, Offers FY22 Guidance
November 3, 2021 7:15 AM EDTScotts Miracle-Gro (NYSE: SMG) reported Q4 EPS of ($0.82), $0.02 better than the analyst estimate of ($0.84). Revenue for the quarter came in at $797.8 million versus the consensus estimate of $689.22 million.
GUIDANCE:
Scotts Miracle-Gro sees FY2022 EPS of $8.50-$8.90, versus the consensus of... More
